We know that as clinical trial protocols are getting more complex, it’s getting more and more difficult to find the right patient to take part in a ...
Continue readingAccelerating clinical studies is a mission that affects us all.
We know that as clinical trial protocols are getting more complex, it’s getting more and more difficult to find the right patient to take part in a ...
Continue readingWith clinical trial protocols becoming ever more complex, it can feel like it’s never been more difficult to find patients who are both eligible for ...
Continue readingWe’re thrilled to share that our CEO, Laurent Schockmel, has been named a top 40 Healthcare Transformer by Medical Marketing & Media (MM&M). ...
Continue readingAntidote recently conducted a survey with SCORR Marketing through which we asked nearly 4,000 patients about their perspectives on clinical trials. ...
Continue readingWith medicine getting ever more targeted and precise, clinical trial protocols are becoming more complex than ever before. While this allows for ...
Continue readingDuring a Q3 2018 survey conducted by Antidote Technologies and SCORR Marketing, we explored specific participation stimuli to determine what could ...
Continue readingDespite decades of research, heart disease continues to be the leading cause of death for both men and women in the United States. It’s clear that ...
Continue readingThe majority of clinical trials don't reach their clinical trial patient recruitment targets on time. Meeting a deadline can feel like a lost cause, ...
Continue readingA significant amount of effort goes into recruiting a patient for a clinical trial, including creating IRB-approved materials, reaching the patient ...
Continue readingFor years, clinical trial patient recruitment has looked the same: identify eligibility criteria for a single trial, conduct traditional media ...
Continue reading